Evidence map›Paper›PMID 41511965›Full record

ArticlePloS one2026

LIMPACAT: Multi-omics attention transformer for immune prediction in liver cancer using whole-slide imaging.

Yen-Jung Chiu

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Yen-Jung ChiuDepartment of Biomedical Engineering, Chang Gung University, Taoyuan, Taiwan.ORCID https://orcid.org/0000-0002-2087-2266

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Characterizing the tumor immune microenvironment from histopathological images offers opportunities for ex vivo immune profiling and prognostic assessment. However, the TCGA-LIHC dataset lacks direct immune cell composition data. Therefore, this study aims to introduce Liver Immune Microenvironment Prediction and Classification Attention Transformer (LIMPACAT), a deep learning framework that leverages whole-slide images (WSIs) to predict immune cell levels relevant to hepatocellular carcinoma (HCC) prognosis. Immune cell compositions were inferred using a deconvolution approach, with bulk RNA-seq profiles simulated from liver-specific single-cell RNA sequencing data and processed with multiple normalization methods. These inferred compositions served as supervision signals to train a multiple instance learning model with an attention transformer. LIMPACAT exhibited ~80% accuracy in classifying immune cell levels from HCC WSIs, showing strong concordance between model prediction and deconvolution-derived estimates. These findings suggest that WSIs can serve as a proxy for immune profiling, facilitating pathology-based tumor microenvironment assessment and supporting personalized therapeutic strategies.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsTumor MicroenvironmentDeep LearningHumansMultiomicsMultiple-Instance Learning AlgorithmsPrognosis

Identifiers

PMID41511965
PMCPMC12788640

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.